Support The Moscow Times!

Reckitt Benckiser Posts Strong Results on Emerging Market Performance

British consumer goods group Reckitt Benckiser said it expected to post annual revenue growth at the top end of forecasts after a strong emerging markets performance and demand for its brands such as Dettol and Strepsils helped it to post first half sales up 6 percent.

To boost growth Reckitt is putting greater focus on its fastest growing health and hygiene brands like Dettol, Strepsils and Durex, and is moving quicker into the key emerging markets of Brazil, Russia, India and China.

The maker of Nurofen painkillers and Cillit Bang cleaners also on Monday said it remained bullish on demand for its heroin addiction drug Suboxone, despite competition from cheaper versions in tablet form.

First half sales rose 6 percent on a constant exchange rate to 5 billion pounds ($7.69 billion).

Read more

Independent journalism isn’t dead. You can help keep it alive.

The Moscow Times’ team of journalists has been first with the big stories on the coronavirus crisis in Russia since day one. Our exclusives and on-the-ground reporting are being read and shared by many high-profile journalists.

We wouldn’t be able to produce this crucial journalism without the support of our loyal readers. Please consider making a donation to The Moscow Times to help us continue covering this historic time in the world’s largest country.